March 12, 2020
Kowa said on March 11 that its Rho kinase inhibitor Glanatec ophthalmic solution (ripasudil) was approved in Singapore for the treatment of open-angle glaucoma and ocular hypertension. The approval was granted on February 18. Kowa plans to establish a direct...read more